847459-98-7

847459-98-7 structure
847459-98-7 structure
  • Name: CRA-026440 hydrochloride
  • Chemical Name: CRA-026440 hydrochloride
  • CAS Number: 847459-98-7
  • Molecular Formula: C23H25ClN4O4
  • Molecular Weight: 456.92
  • Catalog: Signaling Pathways Apoptosis Apoptosis
  • Create Date: 2023-01-14 18:29:17
  • Modify Date: 2025-08-22 20:56:20
  • CRA-026440 hydrochloride is a potent, broad-spectrum HDAC (HDAC) inhibitor. The Ki values against recombinant HDAC isoenzymes HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, and HDAC10 are 4 nM, 14 nM, 11 nM, 15 nM, 7 nM, and 20 nM respectively. CRA-026440 hydrochloride shows antitumor and antiangiogenic activities[1].

Name CRA-026440 hydrochloride
Description CRA-026440 hydrochloride is a potent, broad-spectrum HDAC (HDAC) inhibitor. The Ki values against recombinant HDAC isoenzymes HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, and HDAC10 are 4 nM, 14 nM, 11 nM, 15 nM, 7 nM, and 20 nM respectively. CRA-026440 hydrochloride shows antitumor and antiangiogenic activities[1].
Related Catalog
Target

HDAC1:4 nM (IC50)

HDAC2:14 nM (IC50)

HDAC3/SMRT:11 nM (IC50)

HDAC6:15 nM (IC50)

HDAC8:7 nM (IC50)

HDAC10:20 nM (IC50)

In Vitro CRA-026440 hydrochloride 对 HUVEC 内皮细胞具有抗增殖作用,GI50 值为 1.41 μM[1]。 CRA-026440 hydrochloride(0.1-10 μM;18 小时)导致乙酰化组蛋白和乙酰化微管蛋白的积累,从而抑制肿瘤细胞生长并诱导细胞凋亡[1]。 CRA-026440 hydrochloride(0.1-10 μM;5 天)以剂量依赖性方式抑制离体血管生成[1]。 Western Blot Analysis[1] Cell Line: HCT116 cells Concentration: 0.1 μM, 0.5 μM, 1 μM, 5 μM, 10 μM Incubation Time: 18 hours Result: Resulted in the accumulation of both acetylated histones and acetylated tubulin. Induced expression of the cyclin-dependent kinase inhibitor p21Cip1/WAF1.
In Vivo CRA-026440 hydrochloride(100 mg/kg;静脉注射;每天;连续三天)导致携带 HCT116 或 U937 人肿瘤异种移植物的小鼠肿瘤生长显着减少[1]。 Animal Model: HCT-116 tumor-bearing nude mice[1] Dosage: 100 mg/kg Administration: i.v.; daily; for three consecutive days Result: Resulted in a statistically significant reduction in tumor growth.
References

[1]. [1]Cao ZA, et al. CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo. Mol Cancer Ther. 2006 Jul;5(7):1693-701.  

Molecular Formula C23H25ClN4O4
Molecular Weight 456.92
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.